Results 271 to 280 of about 102,465 (360)

A membranous nephropathy variant mimicking minimal change disease

The Journal of Pathology: Clinical Research, Volume 12, Issue 1, January 2026.
Abstract This study characterizes a novel disease pattern of membranous nephropathy (MN) that exhibits overlapping clinicopathological features with minimal change disease (MCD), termed ‘MCD‐like MN’. Patients with histologically confirmed MN showing sparse and segmental subepithelial electron‐dense deposits (EDD) but clinically resembling MCD were ...
Chuqi Pan, Silin Xiang, Mengya Jiang, Yuan Li, Biao Huang, Tian Ye, Yuanyuan Du, Xuanli Tang, Yuan Yuan   +8 more
wiley   +1 more source

Bone‐Derived dECM Hydrogels Support Tunable Microenvironments for In Vitro Osteogenic Differentiation

Advanced Healthcare Materials, Volume 15, Issue 1, 9 January 2026.
A tunable methacrylated decellularized bone matrix hydrogel (dECM‐MA) is developed to support 3D culture of human osteoblasts. The hydrogel preserves bone‐specific ECM cues and allows precise control over mechanical properties. This system provides a customizable platform for studying osteogenic differentiation and modeling bone tissue environments for
Minne Dekker, Luke Hipwood, Akhilandeshwari Ravichandran, Dietmar W. Hutmacher, Christoph Meinert, Jacqui McGovern   +5 more
wiley   +1 more source

Safety assessment of membrane-associated protoporphyrinogen IX oxidase from <i>Enterobacter cloacae</i> expressed in genetically modified crops. [PDF]

GM Crops Food
Wang C, Li W, Attene-Ramos MS, Kessenich C, Calcaterra J, Wang R, Xiang B, Couoh-Cardel S, Hodge-Bell K, Saracco SA.   +9 more
europepmc   +1 more source

Further Studies on the Inhibition of Pepsin by Bile Salts

, 1986
Toshifumi Eto, Ronald K. Tompkins
openalex   +2 more sources

Ueber Pepsin [PDF]

Archiv der Pharmazie, 1871
openaire   +1 more source

Extracellular‐Matrix‐Based Materials from Decellularized Tissue: Opportunities, Challenges, and Future Directions in Regenerative Medicine

Advanced Healthcare Materials, Volume 15, Issue 1, 9 January 2026.
Extracellular matrix‐based materials derived from decellularized tissue (dECM) harness the tissue's native bioactivity to guide repair and regeneration across diverse clinical applications. This perspective highlights clinical uses of dECM biomaterials and advances in fabrication methods such as electrospinning and 3D printing.
Madeline Laude, Vasiliki Kolliopoulos, Antonios G. Mikos, Lisa J. White, Elizabeth Cosgriff‐Hernandez   +4 more
wiley   +1 more source

Examination of artificial oocyst excystation methods in the murine coccidium, Eimeria krijgsmanni. [PDF]

J Vet Med Sci
Tanaka T, Chatani M, Haraguchi A, Matsubayashi M, Ikadai H, Kaneko T, Matsuo T.   +6 more
europepmc   +1 more source

Development of a Scoring System to Predict the Treatment Success for Nonoperative Management of Peptic Ulcer Perforation: A Secondary Data Analysis of PPAP Study

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 95-102, January 2026.
ABSTRACT Background Although surgical treatment is the primary measure for patients with perforated peptic ulcer (PPU), nonoperative management (NOM) has become a common alternative. However, risk score models predicting the success of NOM based on the analysis of a large number of patients remain scarce.
Kei Ito, Akira Endo, Hiromasa Hoshi, Koji Ito, Tomohiro Akutsu, Hikaru Odera, Hideto Shiraki, Takeshi Yokoyama, Yasukazu Narita, Taro Masuda, Akira Suekane, Shigeru Yamagishi, Koji Morishita   +12 more
wiley   +1 more source

Bioactive Plant Peptides: Physicochemical Features, Structure-Function Insights and Mechanism of Action. [PDF]

Molecules
Avilés-Gaxiola S, García-Aguiar I, Jiménez-Ortega LA, Gutiérrez-Grijalva EP, Heredia JB.   +4 more
europepmc   +1 more source

A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study

American Journal of Hematology, Volume 101, Issue 1, Page 79-88, January 2026.
The WAVe stdudy‐ A multicenter prospective cohort study of wieght‐adjusted dalteparin in patients over 90 kg with acute cancer‐associated venous thromboembolism. ABSTRACT Patients with cancer‐associated thrombosis (CAT) are commonly treated with low‐molecular‐weight heparin (LMWH), but whether dose capping is needed in patients over 90 kg is unclear ...
Tzu‐Fei Wang, Erik Yeo, Peter L. Gross, Chantal Séguin, Cynthia Wu, Sudeep Shivakumar, Ranjeeta Mallick, Aurélien Delluc, Julien D'Astous, Miriam Kimpton, Guillaume Roberge, Deborah M. Siegal, Tobias Tritschler, Grégoire Le Gal, Marc Carrier   +14 more
wiley   +1 more source